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Atrophy of the gastric mucosa is a precursor of intestinal-type gastric cancer,  and Helicobacter pylori 
infection causes atrophic gastritis.  The aim of this study was to determine whether the genetic diver-
sity of H. pylori virulence genes is associated with the development and progression of gastric atrophy 
in humans.  We isolated and cultured H. pylori strains from patients with gastric ulcer and duodenal 
ulcer accompanied by atrophic gastritis in background mucosa.  H. pylori strains were stored at －80℃ 
prior to the experiments being carried out.  We analyzed iceA,  babA,  vacA,  cagA,  and cagE genes by 
PCR.  The cagA gene was analyzed through sequencing of the C-terminal region containing the EPIYA 
motif,  which is related to tyrosine phosphorylation.  Severe atrophy was observed in patients with 
gastric ulcer.  The major phenotype of the vacA gene was s1c/m1 (93ｵ).  The cagA gene was detected 
in all strains.  The cagE gene was not detected in 2 and 5 strains from the mild cases and severe cases,  
respectively.  The major cagA EPIYA motif,  which is amino acids repeat in the C terminus,  was the 
A-B-D type (44 of 58 strains).  The virulence genes were not statistically associated with the severity of 
atrophy in the background gastric mucosa in humans.  Not only identiﬁcation of bacterial virulence 
factors but also studies of the host response will be necessary to investigate the progression of gastric 
atrophy and subsequent cancer development in humans.
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trophy in the stomach is conventionally deﬁned 
as loss of glandular tissue from repeated or 
continuing mucosal injury and is a common denomina-
tor in all pathological processes causing progressive 
mucosal damage,  including long-standing Helicobacter 
pylori infection.  Chronic atrophic gastritis (CAG) is an 
established precursor of intestinal-type gastric cancer,  
which is the second most common cause of cancer-
related deaths worldwide [1,  2].  H. pylori infection 
has been identiﬁed as a major risk factor for both 
gastric inﬂammation and carcinogenesis [3].  Only a 
few patients develop symptomatic diseases such as 
ulcers with clinical symptoms,  MALT lymphoma,  or 
gastric cancer despite one-half of the population in 
Japan being infected with H. pylori.  This clinical 
diversity is assumed to be caused by the interplay of 
environmental factors,  host susceptibility,  and diver-
sity in the pathogenicity of diﬀerent H. pylori strains.
　 Bacterial virulence genes such as vacuolating toxin 
(vacA) and cytotoxin-associated gene A (cagA),  which 
A
Acta Med.  Okayama,  2013
Vol.  67,  No.  2,  pp.  93ﾝ98
CopyrightⒸ 2013 by Okayama University Medical School.
Original Article http ://escholarship.lib.okayama-u.ac.jp/amo/
Received july 23, 2012 ; accepted October 29, 2012.
＊Corresponding author. Phone : ＋81ﾝ86ﾝ235ﾝ6846; Fax : ＋81ﾝ86ﾝ235ﾝ6846
E-mail : yokochan@md.okayama-u.ac.jp (K. Yokota)
have long been established as important virulence fac-
tors of H. pylori,  play important roles in CAG [4-11].  
The vacuolating cytotoxin (vacA),  which is encoded by 
the vacA gene,  is a virulence factor of H. pylori that 
has been associated with epithelial cell damage.  This 
cytotoxin is present in all H. pylori strains and com-
prises 2 variable parts in the vacA gene: the s-region 
(signal) and the m-region (middle).  While vacA s1/m1 
strains produce higher levels of vacA activity in vitro 
than vacA s1/m2 strains do,  vacA s2/m2 strains do not 
produce any detectable activity.  CagA undergoes 
tyrosine phosphorylation [12].  Phosphorylation of 
CagA occurs within the C-terminus of the protein and 
is mediated by members of the Src family of tyrosine 
kinases [13].  The major phosphorylation motif is a 
cluster of Glu-Pro-Ile-Tyr-Ala (EPIYA) sequence 
repeats that share homology to c-Src consensus phos-
phorylation sites.  The number of these EPIYA motifs 
varies from 1-5 repeat units depending on the indi-
vidual CagA protein species [13].  According to the 
C-terminal sequence of the EPIYA motifs of cagA,  
there are 2 types of H. pylori strains: the East Asian 
cagA (A-B-D) and Western cagA (A-B-C) types.  The 
degree of gastric inﬂammation,  activity of gastritis,  
and atrophy are signiﬁcantly higher in patients 
infected with the East Asian cagA-type strains than in 
patients infected with the cagA-negative or the 
Western-cagA-type strains due to the high capability 
of phosphorylated CagA to bind to tyrosine phos-
phatase SHP-2.  In addition,  the adhesion molecules 
of IceA and BabA are also associated with some dis-
eases in Western countries.  There is greater preva-
lence of iceA2-positive strains reported among patients 
with non-ulcer dyspepsia,  while H. pylori strains pos-
sessing the iceA1 allele are more prevalent in peptic 
ulcer disease.  Bacterial attachment to the human 
gastric epithelial lining mediated by the fucosylated 
Lewis b (Leb) histo-blood group antigen and the Leb-
binding adhesion BabA of some H. pylori strains have 
been shown to contribute to the bacteriumʼs pathoge-
nicity [14].  However,  an association between these 
genes and progression of atrophy has not been reported.
　 We previously demonstrated that the grade of 
gastric atrophy is closely related to the development 
of gastric cancer after receiving H. pylori eradication 
therapy [15].  In this study,  we isolated H. pylori 
strains from age-matched patients with severe and mild 
CAG.  Then,  we examined whether the presence of 
individual virulence genes was associated with the 
progression of gastric atrophy in these patients.
Materials and Methods
　 Subjects. Patients (n＝58 cases; average: 51.9 
years; range,  47-63 years) on whom an upper endos-
copy had been carried out were recruited for this 
study.  They were diagnosed at Okayama University 
Hospital and Nippon Kokan Fukuyama Hospital as 
having a digestive ulcer with atrophic gastritis,  and 
then followed up for 10 years [15].  Gastric mucosal 
atrophy was evaluated according to the endoscopic 
atrophic border scale described by Kimura and 
Takemoto [16,  17],  which correlates with the results 
of histologic evaluation [18,  19].  Atrophy was clas-
siﬁed as mild (C-1 and C-2 patterns),  moderate (C-3 
and O-1 patterns),  or severe (O-2 and O-3 patterns).
　 The patients were divided into 2 groups: patients 
with mild atrophy (n＝35; C-1 and C2 patterns) and 
patients with severe atrophy (n＝23; O-2 and O3 pat-
terns),  including 4 cases with severe atrophy and 
gastric cancer (Table 1).  The mean ages ± SD of the 
mild atrophy group and severe atrophy groups were 
51.6±4.1 and 52.5±4.2 years,  respectively.  The 
mean ages were not signiﬁcantly diﬀerent between the 
2 groups.
　 Ethical approval was granted by the Ethics 
Committee of the Okayama University and the study 
was conducted in accordance with the principles of the 
Declaration of Helsinki.
　 Bacterial strains. Antral biopsy specimens 
were homogenized under sterile conditions in 100µL 
of sterile saline using a homogenizer.  The homoge-
nate was plated onto selective Brain Heart Infusion 
agar (BHI) with 7ｵ horse blood containing vancomy-
cin (20mg/L),  bacitracin (200mg/L),  and amphoteri-
cin B (2mg/L).  Agar plates were incubated under 
microaerobic conditions at 37℃ for 7 days until small 
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Table 1　 Number of H. pylori isolates from patients with atrophy
Disease Mild atrophy Severe atrophy
Gastric ulcer  9 16
Duodenal ulcer 26  3
Gastric cancer  0  4
Total 35 23
grey translucent colonies appeared.  Gram stains and 
assays for oxidase and urease were performed.  
Colony morphology was consistent with the character-
istic shape of H. pylori colonies.  Single colonies were 
used for DNA extraction.
　 DNA extraction. DNA was extracted from 
bacterial pellets using QuickGene-810 (FUJIFILM) 
according to the manufacturerʼs instructions.  Quan-
tiﬁcation of DNA from all strains was performed 
spectrophotometrically.
　 PCR and sequencing. We used the primers 
for vacA,  cagE,  iceA,  and babA previously reported by 
Chomvarin et al. [20].  PCR for cagA and the 
sequence of its C-terminal region were analyzed 
according to the report by Higashi et al. [21].  DNA 
direct sequencing was performed using a BigDye 
Terminator v.3.1 cycle sequencing kit (Applied 
Biosystems,  Foster City,  CA,  USA) and an ABI 
PRISM 3100-Avant genetic analyzer (Applied 
Biosystems) according to the manufacturerʼs recom-
mendations.  The full-length amino acid sequences of 
each gene were constructed and translocated from the 
nucleotide sequence and aligned and analyzed with 
GENETYX-MAC version 11.2.3 (Software Develop-
ment,  Tokyo,  Japan).
　 Statistical analysis. Fisherʼs exact test or the 
Chi-square test was used for analysis of categorical 
data.  A p-value of ＜0.05 was considered statistically 
signiﬁcant.
Results
　 Severity of atrophy. Patients with gastric 
ulcer showed severe atrophy (64ｵ) in the background 
gastric mucosa,  but severe atrophy was observed in 
only 10ｵ of patients with duodenal ulcer (Table 1).  
Gastric atrophy was signiﬁcantly (Chi square test p 
value＝0.000011) progressed in patients with gastric 
ulcer.
　 Polymorphism of vacA. Fifty-four of the 58 
strains were identiﬁed as the vacA s1/m1 type.  Only 
2 s1/m2 strains were detected in patients with mild 
atrophy,  and 1 s2/m1 strain was detected.  VacA s/m 
genes were not signiﬁcantly (Chi square test p value
＝0.18) associated with atrophy in the Japanese 
patients (Table 2).
　 Presence of the cagA, cagE, iceA, and babA2 
genes. The numbers of strains testing positive for 
cagA,  cagE,  iceA,  and babA2 genes are shown in 
Table 3.  The cagA and babA2 genes were detected in 
all strains.  The cagE gene was detected in 51 (87.9ｵ) 
strains.  The iceA gene was detected in 47 (81.0ｵ) 
strains.  The iceA1 gene was detected in 27 (77.1ｵ) 
of 35 strains from patients with mild atrophy and in 
13 (56.5ｵ) of 23 strains from patients with severe 
atrophy.  The percentages of strains testing positive 
for these genes among the patients with mild or severe 
atrophy are shown in Fig.  1.  However,  of these genes 
were not signiﬁcantly (Chi square test p value＝0.89) 
associated with grade of atrophy.
　 Polymorphism of cagA. Almost all strains 
were the East Asian cagA type.  Mutation of the B 
domain and repeat of the A or B domains were detected 
in some strains.  Only 2 strains of the the Western 
cagA type were detected in the mild atrophy group 
(Table 4).  EPIYA motifs were not signiﬁcantly (Chi 
square test p value＝0.68) associated with grade of 
atrophy.
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Table 2　 Alleles of the vacA gene in H. pylori isolates from patients with gastric atrophy
Allele Mild atrophy (n＝35)
Severe atrophy (n＝23)
Total (n＝58)
Without GC With GC (n＝4)
vacA s1/m1 33 18 3 54
vacA s1/m2  2  0 1  3
 　　　　s1a  8  4 2 14
 　　　　s1b  0  0 0  0
 　　　　s1c 34 16 3 53
vacA s2/m2  0  1 0  1
GC: gastric cancer
Discussion
　 Atrophic gastritis is considered a precursor lesion 
of intestinal-type gastric cancer.  It is unknown whether 
the genetic diversity of H. pylori virulence genes is 
associated with the development and progression of 
atrophic gastritis and cancer in Japanese patients.  A 
study of the European dyspeptic population with 
chronic gastritis indicated that the risk of presenting 
with atrophic gastritis was enhanced by the simultane-
ous presence of anti-cagA and anti-vacA antibodies 
[22].  Another report indicated that CagA,  VacA,  
HcpC,  and GroEL were independent predictors of 
atrophic gastritis and,  in combination,  were strongly 
associated with chronic atrophic gastritis [23].  
These 2 reports were serological investigations,  and 
thus what the association between individual vacA or 
cagA genotypes and atrophy were not well deﬁned.  
This indicated that immune response might play a 
important roles in atrophy in Europeans.  In contrast,  
there have been no reports regarding the association 
between bacterial genotype and atrophy in North-East 
Asians,  including the Japanese.  We have reported 
that genetic diversity in the cagA,  vacA,  babA,  and 
iceA genes from diﬀerent age-matched atrophy groups 
was not detected in this study.
　 Several pathogenic genes associated with diseases 
have been reported.  However,  associations between 
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Fig. 1　 Percentage of positive for cagA,  cagE,  iceA,  babA and 
babA2 The presence of cagA,  cagE,  iceA,  and babA was detected 
by the PCR method.  Percentage of positive samples was calcu-
lated as the number of positive samples divided by the total number 
of samples (mild: 35 samples; severe 23 samples).
Table 3　 Presence of the cagA,  cagE,  iceA,  babA1 and babA2 genes in H. pylori isolates from patients with gastric atrophy
Genes Mild atrophy (n＝35)
Severe atrophy (n＝23)
Total (n＝58)
Without GC With GC (n＝4)
cagA 35 19 4 58
cagE 33 14 4 51
iceA1 27 10 3 40
iceA2  3  4 0  7
babA2 35 19 4 58
GC: gastric cancer
Table 4　 Gene structure of EPIYA motifs of cagA gene in H. pylori isolates from patients with gastric atrophy
EPIYA motifs Mild atrophy (n＝35)
Severe atrophy (n＝23)
Total (n＝58)
Without GC With GC (n＝4)
A-B-D 25 15 4 44
　 A-(B)-D  6  2 0  8
　 A-B-B-D  0  1 0  1
　 A-B-A-B-D  0  1 0  1
　 A-A-B-D-D  1  0 0  1
A-C  2  0 0  2
GC: gastric cancer
pathogenic genes and severity of diseases have not 
been identiﬁed in East Asian countries.  The diversity 
of pathogenic genes is related to geographic and ethnic 
distribution.  A number of investigators have reported 
geographical “enigmas” (i.e.,  African,  Asian,  Indian,  
and Costa Rican enigmas) based on their perceptions 
that the outcomes they expected were not achieved in 
a particular population or region [24-28].  Clinical 
outcomes induced by H. pylori infection in humans may 
be not be associated with genetic types of virulence.
　 In the present study,  we investigated 58 age-matched 
cases randomly selected from among 1342 previously 
reported patients [13].  Because of the small size,  the 
generalizability of our results to broader deﬁnition of 
genotypes and diseases for Japanese patients is lim-
ited.  On the other hand,  some study recently reported 
that the EPIYA motif was important for gastric can-
cer.  Ferreira et al. analyzed 53 strains from European 
patients with atrophic gastritis and carcinoma and 
found that the number of H. pylori EPIYA C motifs 
was important in better deﬁning gastric carcinoma 
risk [28].  A study of 70 South American patients 
indicated that the EPIYA C motif was not associated 
with gastric cancer,  and two SNPs in positions 1039 
and 1041 of cagE showed a highly signiﬁcant associa-
tion with cancer [29].  In our Japanese data,  the 
EPIYA C motif was detected in only 2 strains,  and 
EPIYA A-B-D variation was also not associated with 
grade of atrophy.  The results of this study may pro-
vide preliminary information not to progress atrophy 
to high-risk individuals,  if the eﬀects of these variants 
are conﬁrmed in further investigations.
　 Most of infected subjects develop some degree of 
atrophic chronic gastritis during their lifetime,  but 
despite the fact that CAG is a premalignant condition,  
very few patients develop gastric cancer.  We could not 
determine whether virulence genes are associated with 
the development of gastric mucosa atrophy in this 
study.  We are of the opinion that the development of 
atrophy in the human stomach may also be associated 
with severe inﬂammation and a host immune response 
during lifelong infection with H. pylori.
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